Immunovia AB (publ) (LON:0G8X)
London flag London · Delayed Price · Currency is GBP · Price in SEK
0.2000
-0.0090 (-4.31%)
At close: Feb 3, 2026

Immunovia AB Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
107647139241
Market Cap Growth
12.65%6.75%-86.78%-65.82%-42.38%-15.68%
Enterprise Value
93-038114198
Last Close Price
0.020.030.111.514.237.79
PS Ratio
160.3399.5350.95519.842011.107452.17
PB Ratio
-15.267.961.202.443.914.50
P/TBV Ratio
-9.551.252.704.154.69
EV/Sales Ratio
146.1542.92-415.931650.166136.65
Debt / Equity Ratio
-2.470.060.150.150.080.06
Asset Turnover
0.020.010.010.000.000.00
Inventory Turnover
---2.02--
Quick Ratio
0.631.752.624.558.9113.99
Current Ratio
0.631.822.694.809.0714.05
Return on Equity (ROE)
-827.50%-194.66%-199.13%-49.61%-30.19%-30.52%
Return on Assets (ROA)
-116.92%-104.55%-92.88%-30.09%-18.05%-15.58%
Return on Capital Employed (ROCE)
1141.10%-634.80%-431.40%-69.20%-36.20%-21.50%
Earnings Yield
-99.60%-82.60%-385.60%-28.24%-9.19%-5.41%
FCF Yield
--104.41%-183.25%-29.71%-9.18%-4.62%
Buyback Yield / Dilution
-347.58%-112.20%-72.02%--6.05%-9.05%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.